author_facet Loreth, Desiree
Schuette, Moritz
Zinke, Jenny
Mohme, Malte
Piffko, Andras
Schneegans, Svenja
Stadler, Julia
Janning, Melanie
Loges, Sonja
Joosse, Simon A.
Lamszus, Katrin
Westphal, Manfred
Müller, Volkmar
Glatzel, Markus
Matschke, Jakob
Gebhardt, Christoffer
Schneider, Stefan W.
Belczacka, Iwona
Volkmer, Beate
Greinert, Rüdiger
Yaspo, Marie-Laure
Harter, Patrick N.
Pantel, Klaus
Wikman, Harriet
Loreth, Desiree
Schuette, Moritz
Zinke, Jenny
Mohme, Malte
Piffko, Andras
Schneegans, Svenja
Stadler, Julia
Janning, Melanie
Loges, Sonja
Joosse, Simon A.
Lamszus, Katrin
Westphal, Manfred
Müller, Volkmar
Glatzel, Markus
Matschke, Jakob
Gebhardt, Christoffer
Schneider, Stefan W.
Belczacka, Iwona
Volkmer, Beate
Greinert, Rüdiger
Yaspo, Marie-Laure
Harter, Patrick N.
Pantel, Klaus
Wikman, Harriet
author Loreth, Desiree
Schuette, Moritz
Zinke, Jenny
Mohme, Malte
Piffko, Andras
Schneegans, Svenja
Stadler, Julia
Janning, Melanie
Loges, Sonja
Joosse, Simon A.
Lamszus, Katrin
Westphal, Manfred
Müller, Volkmar
Glatzel, Markus
Matschke, Jakob
Gebhardt, Christoffer
Schneider, Stefan W.
Belczacka, Iwona
Volkmer, Beate
Greinert, Rüdiger
Yaspo, Marie-Laure
Harter, Patrick N.
Pantel, Klaus
Wikman, Harriet
spellingShingle Loreth, Desiree
Schuette, Moritz
Zinke, Jenny
Mohme, Malte
Piffko, Andras
Schneegans, Svenja
Stadler, Julia
Janning, Melanie
Loges, Sonja
Joosse, Simon A.
Lamszus, Katrin
Westphal, Manfred
Müller, Volkmar
Glatzel, Markus
Matschke, Jakob
Gebhardt, Christoffer
Schneider, Stefan W.
Belczacka, Iwona
Volkmer, Beate
Greinert, Rüdiger
Yaspo, Marie-Laure
Harter, Patrick N.
Pantel, Klaus
Wikman, Harriet
International Journal of Molecular Sciences
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
Inorganic Chemistry
Organic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Catalysis
author_sort loreth, desiree
spelling Loreth, Desiree Schuette, Moritz Zinke, Jenny Mohme, Malte Piffko, Andras Schneegans, Svenja Stadler, Julia Janning, Melanie Loges, Sonja Joosse, Simon A. Lamszus, Katrin Westphal, Manfred Müller, Volkmar Glatzel, Markus Matschke, Jakob Gebhardt, Christoffer Schneider, Stefan W. Belczacka, Iwona Volkmer, Beate Greinert, Rüdiger Yaspo, Marie-Laure Harter, Patrick N. Pantel, Klaus Wikman, Harriet 1422-0067 MDPI AG Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis http://dx.doi.org/10.3390/ijms22136993 <jats:p>Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood can serve as a disease surrogate, focusing on CD44 and CD74 expression as prognostic markers for BM. We show that a size-based microfluidic approach in combination with a semi-automated cell recognition system are well suited for CTC detection in BM patients and allow further characterization of tumor cells potentially derived from BM. CTCs were found in 50% (7/14) of breast cancer, 50% (9/18) of non-small cell lung cancer (NSCLC) and 36% (4/11) of melanoma patients. The next-generation sequencing (NGS) analysis of nine single CTCs from one breast cancer patient revealed three different CNV profile groups as well as a resistance causing ERS1 mutation. CD44 and CD74 were expressed on most CTCs and their expression was strongly correlated, whereas matched breast cancer BM tissues were much less frequently expressing CD44 and CD74 (negative in 46% and 54%, respectively). Thus, plasticity of CD44 and CD74 expression during trafficking of CTCs in the circulation might be the result of adaptation strategies.</jats:p> CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis International Journal of Molecular Sciences
doi_str_mv 10.3390/ijms22136993
facet_avail Online
Free
finc_class_facet Physik
Informatik
Biologie
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjIxMzY5OTM
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjIxMzY5OTM
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint MDPI AG, 2021
imprint_str_mv MDPI AG, 2021
issn 1422-0067
issn_str_mv 1422-0067
language English
mega_collection MDPI AG (CrossRef)
match_str loreth2021cd74andcd44expressiononctcsincancerpatientswithbrainmetastasis
publishDateSort 2021
publisher MDPI AG
recordtype ai
record_format ai
series International Journal of Molecular Sciences
source_id 49
title CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_unstemmed CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_full CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_fullStr CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_full_unstemmed CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_short CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_sort cd74 and cd44 expression on ctcs in cancer patients with brain metastasis
topic Inorganic Chemistry
Organic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Catalysis
url http://dx.doi.org/10.3390/ijms22136993
publishDate 2021
physical 6993
description <jats:p>Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood can serve as a disease surrogate, focusing on CD44 and CD74 expression as prognostic markers for BM. We show that a size-based microfluidic approach in combination with a semi-automated cell recognition system are well suited for CTC detection in BM patients and allow further characterization of tumor cells potentially derived from BM. CTCs were found in 50% (7/14) of breast cancer, 50% (9/18) of non-small cell lung cancer (NSCLC) and 36% (4/11) of melanoma patients. The next-generation sequencing (NGS) analysis of nine single CTCs from one breast cancer patient revealed three different CNV profile groups as well as a resistance causing ERS1 mutation. CD44 and CD74 were expressed on most CTCs and their expression was strongly correlated, whereas matched breast cancer BM tissues were much less frequently expressing CD44 and CD74 (negative in 46% and 54%, respectively). Thus, plasticity of CD44 and CD74 expression during trafficking of CTCs in the circulation might be the result of adaptation strategies.</jats:p>
container_issue 13
container_start_page 0
container_title International Journal of Molecular Sciences
container_volume 22
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348408254562304
geogr_code not assigned
last_indexed 2024-03-01T18:09:56.781Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=CD74+and+CD44+Expression+on+CTCs+in+Cancer+Patients+with+Brain+Metastasis&rft.date=2021-06-29&genre=article&issn=1422-0067&volume=22&issue=13&pages=6993&jtitle=International+Journal+of+Molecular+Sciences&atitle=CD74+and+CD44+Expression+on+CTCs+in+Cancer+Patients+with+Brain+Metastasis&aulast=Wikman&aufirst=Harriet&rft_id=info%3Adoi%2F10.3390%2Fijms22136993&rft.language%5B0%5D=eng
SOLR
_version_ 1792348408254562304
author Loreth, Desiree, Schuette, Moritz, Zinke, Jenny, Mohme, Malte, Piffko, Andras, Schneegans, Svenja, Stadler, Julia, Janning, Melanie, Loges, Sonja, Joosse, Simon A., Lamszus, Katrin, Westphal, Manfred, Müller, Volkmar, Glatzel, Markus, Matschke, Jakob, Gebhardt, Christoffer, Schneider, Stefan W., Belczacka, Iwona, Volkmer, Beate, Greinert, Rüdiger, Yaspo, Marie-Laure, Harter, Patrick N., Pantel, Klaus, Wikman, Harriet
author_facet Loreth, Desiree, Schuette, Moritz, Zinke, Jenny, Mohme, Malte, Piffko, Andras, Schneegans, Svenja, Stadler, Julia, Janning, Melanie, Loges, Sonja, Joosse, Simon A., Lamszus, Katrin, Westphal, Manfred, Müller, Volkmar, Glatzel, Markus, Matschke, Jakob, Gebhardt, Christoffer, Schneider, Stefan W., Belczacka, Iwona, Volkmer, Beate, Greinert, Rüdiger, Yaspo, Marie-Laure, Harter, Patrick N., Pantel, Klaus, Wikman, Harriet, Loreth, Desiree, Schuette, Moritz, Zinke, Jenny, Mohme, Malte, Piffko, Andras, Schneegans, Svenja, Stadler, Julia, Janning, Melanie, Loges, Sonja, Joosse, Simon A., Lamszus, Katrin, Westphal, Manfred, Müller, Volkmar, Glatzel, Markus, Matschke, Jakob, Gebhardt, Christoffer, Schneider, Stefan W., Belczacka, Iwona, Volkmer, Beate, Greinert, Rüdiger, Yaspo, Marie-Laure, Harter, Patrick N., Pantel, Klaus, Wikman, Harriet
author_sort loreth, desiree
container_issue 13
container_start_page 0
container_title International Journal of Molecular Sciences
container_volume 22
description <jats:p>Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood can serve as a disease surrogate, focusing on CD44 and CD74 expression as prognostic markers for BM. We show that a size-based microfluidic approach in combination with a semi-automated cell recognition system are well suited for CTC detection in BM patients and allow further characterization of tumor cells potentially derived from BM. CTCs were found in 50% (7/14) of breast cancer, 50% (9/18) of non-small cell lung cancer (NSCLC) and 36% (4/11) of melanoma patients. The next-generation sequencing (NGS) analysis of nine single CTCs from one breast cancer patient revealed three different CNV profile groups as well as a resistance causing ERS1 mutation. CD44 and CD74 were expressed on most CTCs and their expression was strongly correlated, whereas matched breast cancer BM tissues were much less frequently expressing CD44 and CD74 (negative in 46% and 54%, respectively). Thus, plasticity of CD44 and CD74 expression during trafficking of CTCs in the circulation might be the result of adaptation strategies.</jats:p>
doi_str_mv 10.3390/ijms22136993
facet_avail Online, Free
finc_class_facet Physik, Informatik, Biologie, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9pam1zMjIxMzY5OTM
imprint MDPI AG, 2021
imprint_str_mv MDPI AG, 2021
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 1422-0067
issn_str_mv 1422-0067
language English
last_indexed 2024-03-01T18:09:56.781Z
match_str loreth2021cd74andcd44expressiononctcsincancerpatientswithbrainmetastasis
mega_collection MDPI AG (CrossRef)
physical 6993
publishDate 2021
publishDateSort 2021
publisher MDPI AG
record_format ai
recordtype ai
series International Journal of Molecular Sciences
source_id 49
spelling Loreth, Desiree Schuette, Moritz Zinke, Jenny Mohme, Malte Piffko, Andras Schneegans, Svenja Stadler, Julia Janning, Melanie Loges, Sonja Joosse, Simon A. Lamszus, Katrin Westphal, Manfred Müller, Volkmar Glatzel, Markus Matschke, Jakob Gebhardt, Christoffer Schneider, Stefan W. Belczacka, Iwona Volkmer, Beate Greinert, Rüdiger Yaspo, Marie-Laure Harter, Patrick N. Pantel, Klaus Wikman, Harriet 1422-0067 MDPI AG Inorganic Chemistry Organic Chemistry Physical and Theoretical Chemistry Computer Science Applications Spectroscopy Molecular Biology General Medicine Catalysis http://dx.doi.org/10.3390/ijms22136993 <jats:p>Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood can serve as a disease surrogate, focusing on CD44 and CD74 expression as prognostic markers for BM. We show that a size-based microfluidic approach in combination with a semi-automated cell recognition system are well suited for CTC detection in BM patients and allow further characterization of tumor cells potentially derived from BM. CTCs were found in 50% (7/14) of breast cancer, 50% (9/18) of non-small cell lung cancer (NSCLC) and 36% (4/11) of melanoma patients. The next-generation sequencing (NGS) analysis of nine single CTCs from one breast cancer patient revealed three different CNV profile groups as well as a resistance causing ERS1 mutation. CD44 and CD74 were expressed on most CTCs and their expression was strongly correlated, whereas matched breast cancer BM tissues were much less frequently expressing CD44 and CD74 (negative in 46% and 54%, respectively). Thus, plasticity of CD44 and CD74 expression during trafficking of CTCs in the circulation might be the result of adaptation strategies.</jats:p> CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis International Journal of Molecular Sciences
spellingShingle Loreth, Desiree, Schuette, Moritz, Zinke, Jenny, Mohme, Malte, Piffko, Andras, Schneegans, Svenja, Stadler, Julia, Janning, Melanie, Loges, Sonja, Joosse, Simon A., Lamszus, Katrin, Westphal, Manfred, Müller, Volkmar, Glatzel, Markus, Matschke, Jakob, Gebhardt, Christoffer, Schneider, Stefan W., Belczacka, Iwona, Volkmer, Beate, Greinert, Rüdiger, Yaspo, Marie-Laure, Harter, Patrick N., Pantel, Klaus, Wikman, Harriet, International Journal of Molecular Sciences, CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis, Inorganic Chemistry, Organic Chemistry, Physical and Theoretical Chemistry, Computer Science Applications, Spectroscopy, Molecular Biology, General Medicine, Catalysis
title CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_full CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_fullStr CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_full_unstemmed CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_short CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
title_sort cd74 and cd44 expression on ctcs in cancer patients with brain metastasis
title_unstemmed CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
topic Inorganic Chemistry, Organic Chemistry, Physical and Theoretical Chemistry, Computer Science Applications, Spectroscopy, Molecular Biology, General Medicine, Catalysis
url http://dx.doi.org/10.3390/ijms22136993